FRIDAY, JULY 21, 2017

Study indicates new strategy to treat tuberculosis

Researchers at Johns Hopkins University School of Medicine recently created a new treatment strategy using lower doses of a toxic tuberculosis drug without losing its efficacy. Read More »

Mylan to supply ARV drugs to South Africa for three years

Mylan, Inc., said on Wednesday that its subsidiary in India, Mylan Laboratories, Ltd., has been chosen to be a top supplier of antiretroviral (ARV) medications to the South African National Department of Health. Read More »

Shingles vaccine shows promise in test subjects age 50 and up

GlaxoSmithKline (GSK) has created a new vaccine that in a recent Zoster Efficacy study demonstrated the ability to reduce shingles in people 50 and older, the Center for the Biology of Chronic Disease (CBCD) said Wednesday. Read More »